These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7754539)

  • 21. A rare case of successfully treated cardiac metastasis from transitional cell bladder cancer.
    Doshi TV; Doshi JV; Makaryus JN; Makaryus AN
    Am J Ther; 2013; 20(3):307-10. PubMed ID: 21436764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer.
    Dhote R; Beuzeboc P; Thiounn N; Flam T; Zerbib M; Christoforov B; Debré B
    Eur Urol; 1998; 33(4):392-5. PubMed ID: 9612683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival in bone-predominant metastatic urothelial carcinoma.
    Ramos JD; Cheng HH; Yu EY
    Clin Genitourin Cancer; 2014 Dec; 12(6):e241-4. PubMed ID: 25160520
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multidisciplinary treatment for advanced bladder cancer--a case report].
    Watanabe Y; Itoh S; Mitsuhata N
    Gan To Kagaku Ryoho; 2004 May; 31(5):793-6. PubMed ID: 15170995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
    Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP
    J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line chemotherapy in advanced bladder cancer.
    Pavone-Macaluso M; Sternberg C
    Urol Int; 2000; 64(2):61-9. PubMed ID: 10810266
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of disseminated disease in the patient with bladder cancer.
    Perry JJ; Muss HB
    Urol Clin North Am; 1994 Nov; 21(4):661-72. PubMed ID: 7974898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic therapy of bladder cancer.
    Salem PA
    Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy with mitomycin C, folic acid and 5-fluorouracil in treatment of metastatic, refractory urinary bladder carcinoma--phase II study].
    Otto T; Krege S; Otto B; Goepel M; Rübben H
    Urologe A; 1997 May; 36(3):243-7. PubMed ID: 9265345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature.
    Messina C; Zanardi E; Dellepiane C; Tomasello L; Colecchia M; Ravetti GL; Boccardo F; Spina B
    Clin Genitourin Cancer; 2016 Feb; 14(1):e139-42. PubMed ID: 26627132
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
    El-Ghobashy S; El-Leithy TR; Roshdy MM; El-Ganzoury HM
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):121-6. PubMed ID: 19034342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for bladder cancer.
    Whitmore WF
    J Urol; 1985 Dec; 134(6):1181-2. PubMed ID: 3932688
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment of metastatic skin lesions with electrochemotherapy.
    Kubota Y; Mir LM; Nakada T; Sasagawa I; Suzuki H; Aoyama N
    J Urol; 1998 Oct; 160(4):1426. PubMed ID: 9751373
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined thiotepa and mitomycin C instillation therapy for low-grade superficial bladder tumor.
    Hu KN; Kim A; Khan AS; Soroff H; Gonder M
    Cancer; 1985 Apr; 55(8):1654-8. PubMed ID: 3156664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous metastases from transitional cell carcinoma of the bladder.
    Block CA; Dahmoush L; Konety BR
    Urology; 2006 Apr; 67(4):846.e15-7. PubMed ID: 16600346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).
    Choi YJ; Lee SH; Lee JL; Ahn JH; Lee KH; You D; Hong B; Hong JH; Ahn H
    Br J Cancer; 2015 Jan; 112(2):260-5. PubMed ID: 25429526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder cancer chemotherapy: is response of squamous tumours different to that of transitional cell tumours?
    Oliver RT
    Ann Oncol; 1991 Feb; 2(2):87-8. PubMed ID: 1711366
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions.
    Lorusso V; Silvestris N
    Ann Oncol; 2005 May; 16 Suppl 4():iv85-89. PubMed ID: 15923437
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP
    Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitomycin-C and lonidamine as second-line therapy for colorectal cancer: a phase II study.
    Zaniboni A; Meriggi F; Alghisi A; Mutti S; Distefano L; Rizzi A; Bettini L; Simoncini E; Marpicati P; Montini E
    Tumori; 1995; 81(6):435-7. PubMed ID: 8804471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.